Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Regimens in Younger Adult Patients With BCR-ABL-Negative ALL
NCT00131053Phase 2Unknown
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Sep 2002
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methotrexate, prednisolone, dexamethasone, vincristine, pirarubicin and 5 more in acute lymphoblastic leukemia (ALL), sponsored by Japan Adult Leukemia Study Group. Primary endpoint: Disease-free survival at 3 years. Status: unknown.
02
Drugs
methotrexateprednisolonedexamethasonevincristinepirarubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00131053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131053.